CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Cen...
Chicago, Illinois, United States
This study is designed to evaluate the safety and effectiveness of endoscopic intestinal re-cellularization therapy in individuals with type 2 diabetes...
Evanston, Illinois, United States and 44 other locations
inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...
Phase 3
Chicago, Illinois, United States and 17 other locations
blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...
Phase 2
Chicago, Illinois, United States and 26 other locations
placebo-controlled, multicenter to evaluate the efficacy, safety, and tolerability of AZD6234 in adults with overweight or obesity and type 2 diabetes...
Phase 2
Chicago, Illinois, United States and 17 other locations
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...
Phase 2
Chicago, Illinois, United States and 6 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Chicago, Illinois, United States and 40 other locations
This study is testing whether a new medication called CX11 works and is safe for participants with type 2 diabetes who have not reached good...
Phase 2
Chicago, Illinois, United States and 45 other locations
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 day...
Phase 3
Chicago, Illinois, United States and 87 other locations
Phase 2 dose (RP2D) in adult subjects with unstable Type 1 Diabetes Mellitus (T1DM) and a level 3 (severe) hypoglycemic episode at least thr...
Phase 1, Phase 2
Chicago, Illinois, United States
Clinical trials
Research sites
Resources
Legal